Blogs

It is with great sadness that we at OHC announce the May 1 retirement of our dear friend, and one of our five founding physicians, Doug Hawley, M.D. In a letter sent to his patients, Dr. Hawley explained, “I love what I do now; I am as   (Read More)

We’re so excited over here. LEAD Cincinnati magazine has just featured OHC in an article by reporter Rick Bird. It’s titled, “Behind the Scenes of One of the Region’s Premier Provider of Cancer Care.” We encourage you to   (Read More)

We’re so excited over here. LEAD Cincinnati magazine has just featured OHC in an article by reporter Rick Bird. It’s titled, “Behind the Scenes of One of the Region’s Premier Provider of Cancer Care.” We encourage you to   (Read More)

Lymphomas, blood cell tumors that usually originate in lymphatic tissues (and can spread to other organs), are among the most diverse and most curable of all malignancies. There are two major groups of lymphomas: About 90 percent are non-Hodgkin   (Read More)

The OHC Research Department’s robust clinical trial menu provides an opportunity for patients in and around the Tri-state to participate in innovative studies which include targeted therapies. OHC’s history of successful participation in   (Read More)

There are basically five things to know. 1) You will see your OHC physician (a radiation oncologist) at the office, during which your radiation treatments will be discussed. At this visit, be sure to tell your doctor or nurse any medications you are   (Read More)

At the beginning of our interview, I’m cautioned by his daughter that cancer survivor Charles Spencer will cry at the drop of a hat whenever he talks about OHC Medical Oncologist Dr. James Essell and the role he played in saving his life. Charles   (Read More)

Mercy Health’s Blood Cancer Center — whose Blood and Marrow Transplant team is powered by OHC physicians — has earned the Joint Commission’s Certification and Gold Seal of Approval®. “The diagnosis of blood cancer is a terrible shock   (Read More)

Mercy Health’s Blood Cancer Center — whose Blood and Marrow Transplant team is powered by OHC physicians — has earned the Joint Commission’s Certification and Gold Seal of Approval®. “The diagnosis of blood cancer is a terrible shock   (Read More)

We have tremendous news to share with you on a breakthrough cancer treatment. The FDA has approved the anti–PD-1 agent nivolumab (Opdivo) for the treatment of patients with advanced squamous non–small cell lung cancer (NSCLC) who have progressed   (Read More)

Not all cancers are the same. This fact has been known for years. But recently, that notion has taken on a new meaning. Cancer research has historically classified cancers by the anatomic site, or where it occurred in the body. The belief was that   (Read More)

March is Colorectal Cancer Month. And it comes with good news. Small to big strides are being made every day in determining new, more effective treatment options. We can say this with first-hand experience and authority, as OHC is a regional leader   (Read More)

St. Patrick’s Day is just three weeks away on March 17. And with it comes a longing for everything green, from green beer to anything that originates from the greenest place on Earth, the Emerald Isle. Ireland also gives us food staples like root   (Read More)

St. Patrick’s Day is just three weeks away on March 17. And with it comes a longing for everything green, from green beer to anything that originates from the greenest place on Earth, the Emerald Isle. Ireland also gives us food staples like root   (Read More)

From 9-11pm on March 30, 31, and April 1, local Public Broadcasting Station CET will air the new 6-hour Ken Burns production, Cancer: The Emperor of All Maladies. We strongly encourage you to put this important documentary on your calendar. We also   (Read More)